Preliminary Recommendations for Surgical Practice of Neurosurgery Department in the Central Epidemic Area of 2019 Coronavirus Infection

Abstract

Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) has posed significant threats to the public health and life in China. Unlike the other 6 identified coronaviruses, the SARS-Cov-2 has a high infectious rate, a long incubation period and a variety of manifestations. In the absence of effective treatments for the virus, it becomes extremely urgent to develop scientific and standardized proposals for prevention and control of virus transmission. Hereby we focused on the surgical practice in Neurosurgery Department, Tongji Hospital, Wuhan, and drafted several recommendations based on the latest relevant guidelines and our experience. These recommendations have helped us until now to achieve ‘zero infection’ of doctors and nurses in our department, we would like to share them with other medical staff of neurosurgery to fight 2019-nCoV infection.

Keywords

SARS-CoV-2 / Neurosurgery / Diagnosis / Treatment / Prevention

References

[1] ChenN, ZhouM, DongX, et al.. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet, 2020, 395(10223): 507-513

[2] WuF, ZhaoS Y %, et al.. A new coronavirus associated with human respiratory disease in China. Nature, 2020

[3] PanX, OjciusDM, GaoT, et al.. Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases. Microbes Infect, 2020

[4] SunP, LuX, XuC, et al.. Understanding of COVID-19 based on current evidence. J Med Virol, 2020

[5] ZhaoWM, SongSH, ChenML, et al.. The 2019 novel coronavirus resource. Yi Chuan, 2020, 42(2): 212-221

[6] LuR, ZhaoX, LiJ, et al.. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 2020, 395(10224): 565-574

[7] RalphR, LewJ, ZengT, et al.. 2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness. J Infect Dev Ctries, 2020, 14(1): 3-17

[8] WangD, HuB, HuC, et al.. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 2020

[9] LaiCC, ShihTP, KoWC, et al.. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents, 2020105924

[10] AiT, YangZ, HouH, et al.. Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology, 2020200642

[11] ShanmugarajB, MallaA, PhoolcharoenW. Emergence of Novel Coronavirus 2019-nCoV: Need for Rapid Vaccine and Biologics Development. Pathogens, 2020, 9(2): 148-150

[12] KwokKO, WongV, WeiVWI, et al.. Novel coronavirus (2019-nCoV) cases in Hong Kong and implications for further spread. J Infect, 2020